Optimising the Management of FLT3mut+ R/R AML - report from EHA2025

Medical Digest & Congress Report
25/06/2025 6 min

Listen "Optimising the Management of FLT3mut+ R/R AML - report from EHA2025"

Descargar episodio Ver en sitio original

Episode Synopsis

Professor Mark Levis shares his insights on optimising the management of FLT3mut+ R/R AML at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:optimising-management-flt3mut-rr-aml

More episodes of the podcast Medical Digest & Congress Report

Thoracic oncology - Lung cancer screening updates: switch gears to move forward - report from ERS 2025 13/10/2025
Advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines - report from ERS 2025 13/10/2025
Horizon scanning in the treatment of interstitial lung diseases- report from ERS 2025 13/10/2025
Addressing the generational challenge in lung health amidst the growing number of novel tobacco products - report from ERS 2025 13/10/2025
The emerging therapeutic interventions for the management of interstitial lung diseases - report from ERS 2025 13/10/2025
Current controversies in interstitial lung diseases - report from ERS 2025 13/10/2025
Prevention in action: prevention in the joint action on respiratory disease - report from ERS 2025 13/10/2025
Understanding aging mechanisms and their effect in asthma - report from ERS 2025 09/10/2025
Lung cancer and severe respiratory comorbidities: navigating complex clinical challenges - report from ERS 2025 09/10/2025
Benefits of twice daily inhaler dosage in the treatment of COPD - report from ERS 2025 09/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA